Welcome to our dedicated page for Accenture Plc Ireland SEC filings (Ticker: ACN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Accenture plc (ACN) SEC filings page brings together the company’s official disclosures to the U.S. Securities and Exchange Commission, including annual and quarterly financial reports, proxy materials and current reports on significant events. As a New York Stock Exchange‑listed company incorporated in Ireland, Accenture uses these filings to provide detailed information on its financial performance, governance, strategy and material developments.
Accenture’s Form 8‑K current reports frequently furnish earnings releases for quarterly and annual periods, outlining revenues, operating margin, earnings per share, bookings, free cash flow and other key metrics. These 8‑K filings also describe the company’s use of non‑GAAP measures such as free cash flow, local‑currency growth and adjusted results that exclude specified business optimization costs, along with reconciliations to GAAP figures. Other 8‑K filings disclose leadership and organizational changes, including updates to Accenture’s growth model and senior management roles.
The company’s definitive proxy statement (DEF 14A) provides extensive detail on corporate governance, board structure, director nominees, executive compensation programs, share incentive plans and shareholder proposals. It also discusses Accenture’s strategy to be the reinvention partner of choice for clients, its Reinvention Services structure, and multi‑year trends in revenue growth, margins, earnings and cash returned to shareholders.
Through this page, users can access Accenture’s 10‑K annual reports, 10‑Q quarterly reports, 8‑K current reports, proxy statements and related exhibits as they are filed with the SEC’s EDGAR system. Stock Titan enhances these documents with AI‑powered summaries that highlight the main points of lengthy filings, explain non‑GAAP reconciliations, and surface items such as compensation plans and governance proposals. Investors tracking ACN can use these filings to review historical performance, understand management’s reporting practices and monitor material events affecting the company.
John F. Walsh, an officer of Accenture plc, reported a purchase of Class A ordinary shares. On 09/05/2025 he acquired 108 shares at a price of $254.42 per share under Accenture's Voluntary Equity Investment Program, bringing his reported direct beneficial ownership to 16,298 Class A ordinary shares. The Form 4 was signed on behalf of Mr. Walsh by an attorney-in-fact on 09/08/2025.
Catherine Kiernan Hogan, Chief Operating Officer of Accenture plc (ACN), reported an equity purchase on 09/05/2025. She acquired 8,669 Class A ordinary shares at a price of $254.42 per share through Accenture's Voluntary Equity Investment Program. The filing also reports 2,048 Class A ordinary shares held indirectly in a family trust. The Form 4 was signed on behalf of Ms. Hogan by an attorney-in-fact on 09/08/2025. The disclosure is a routine officer purchase under the company plan.
Joel Unruch, Accenture plc's General Counsel and Corporate Secretary, acquired 108 Class A ordinary shares on 09/05/2025 at a reported price of $254.42 per share under Accenture's Voluntary Equity Investment Program. After the purchase, Mr. Unruch beneficially owns 17,807 shares directly. The transaction was reported on a Form 4 and executed by an attorney-in-fact on behalf of the reporting person. This appears to be a routine, plan-driven equity purchase rather than an open-market discretionary trade.
Catherine Kiernan Hogan, Chief Operating Officer of Accenture plc (ACN), filed an initial Form 3 reporting her beneficial ownership of Accenture securities. The filing shows 8,585 Class A ordinary shares held directly and 2,048 Class A ordinary shares held indirectly through a family trust. The event requiring the statement is dated 09/01/2025, and the Form 3 was signed on 09/02/2025.
Accenture plc reporting person Katherine Lee Clifford filed an Initial Statement of Beneficial Ownership showing direct ownership of 4,703 Class A ordinary shares. The Form 3 reports her role as Chief Leadership & HR Officer and indicates the transaction date requiring the statement was 09/01/2025. No derivative securities are reported. The filing was signed by an attorney-in-fact on 09/02/2025.
Jaime Ardila, a director of Accenture plc (ACN), received a grant of restricted share units (RSUs) on 08/15/2025 under the anti-dilution provisions of previously granted RSU awards to reflect Accenture's payment of a cash dividend. The Form 4 reports a non-derivative acquisition (transaction code A) with a reported price of $247.57. Following the reported transaction, Mr. Ardila beneficially owns 12,124 Class A ordinary shares directly. The filing was signed by an attorney-in-fact on 08/18/2025 and includes the explanatory remark that the RSUs were granted pursuant to anti-dilution provisions tied to a dividend.
Martin Brudermueller, an Accenture plc (ACN) director, received 5 restricted share units (RSUs) under anti-dilution provisions tied to prior RSU awards to reflect Accenture's cash dividend. The reported transaction shows an execution price reference of $247.57 per share and indicates 1,128 Class A ordinary shares beneficially owned by the reporting person following the grant. The Form 4 was submitted to disclose this non-derivative acquisition and clarifies the RSUs were granted specifically to adjust awards for the company dividend.
Alan C. Jope, a director of Accenture plc (ACN), reported an acquisition of 1,978 Class A ordinary shares on 08/15/2025. The shares were received as a grant of Restricted Share Units (RSUs) under anti-dilution provisions tied to a cash dividend; the report shows a deemed price of $247.57 per share. Following the transaction, Mr. Jope beneficially owns 1,978 shares directly. The Form 4 was signed by an attorney-in-fact on 08/18/2025. The filing discloses a routine equity award adjustment rather than an open-market trade.
Accenture plc (ACN) Form 4: Director Nancy McKinstry was reported as acquiring restricted share units tied to Accenture Class A ordinary shares on 08/15/2025. The filing shows an acquisition (Code A) related to anti-dilution adjustments for previously granted RSU awards to reflect a cash dividend payment. The reported post-transaction beneficial ownership is 7,260 shares held directly. The transaction is documented with a reported per-share amount of $247.57 and was signed by an attorney-in-fact on behalf of the reporting person on 08/18/2025.
Jennifer Nason, a director of Accenture plc (ACN), reported an acquisition of 619 Class A ordinary shares through the grant of restricted share units (RSUs). The transaction date was 08/15/2025 and the form was filed with a signature dated 08/18/2025.
The RSUs were granted pursuant to the anti-dilution provisions of previously awarded RSU awards to reflect Accenture's payment of a cash dividend. The reported price associated with the RSU grant is $247.57 and ownership is reported as direct.